Liminatus Pharma, Inc. Class A Common Stock (LIMN) — Cash Flow Quality Index
Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a Cash Flow Quality Index of -0.28x as of December 2021. Operating cash flow of $-1.22 Million is below net income of $4.37 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Liminatus Pharma, Inc. Class A Common St cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Liminatus Pharma, Inc. Class A Common Stock Cash Flow Quality Index (2021–2021)
Historical Cash Flow Quality Index for Liminatus Pharma, Inc. Class A Common Stock across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Liminatus Pharma, Inc. Class A Common St generate cash.
Annual Cash Flow Quality Index for Liminatus Pharma, Inc. Class A Common Stock (2021–2021)
Year-by-year earnings quality comparison for Liminatus Pharma, Inc. Class A Common Stock.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -0.28x | $-1.22 Million | $4.37 Million | — |